Skip to main content
TipRanks
Go Ultimate75% OFF

Cannara Biotech (LOVE) Financial Statements

41 Followers

Cannara Biotech Financial Overview

Cannara Biotech's market cap is currently C$199.54M. The company's EPS TTM is C$0.11; its P/E ratio is 17.69; Cannara Biotech is estimated to report earnings on November 30, 2026, and the estimated EPS forecast is C$0.04. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Aug 25Aug 24Nov 23Aug 22Nov 21
Income Statement
Total RevenueC$ 107.32MC$ 81.75MC$ 57.26MC$ 35.84MC$ 17.02M
Gross ProfitC$ 47.22MC$ 29.79MC$ 27.23MC$ 16.74MC$ 11.86M
Operating IncomeC$ 22.20MC$ 10.08MC$ 11.89MC$ 4.39MC$ 1.82M
EBITDAC$ 28.46MC$ 15.16MC$ 15.77MC$ 7.85MC$ 4.63M
Net IncomeC$ 13.08MC$ 6.44MC$ 6.95MC$ 2.31MC$ -1.53M
Balance Sheet
Cash & Short-Term InvestmentsC$ 14.36MC$ 6.62MC$ 4.27MC$ 12.11MC$ 8.16M
Total AssetsC$ 168.65MC$ 154.72MC$ 141.52MC$ 125.62MC$ 92.02M
Total DebtC$ 41.58MC$ 48.33MC$ 45.78MC$ 48.39MC$ 20.90M
Net DebtC$ 27.22MC$ 41.71MC$ 41.51MC$ 36.28MC$ 12.74M
Total LiabilitiesC$ 66.43MC$ 66.77MC$ 61.78MC$ 58.88MC$ 27.91M
Stockholders' EquityC$ 102.22MC$ 87.95MC$ 79.74MC$ 66.74MC$ 64.12M
Cash Flow
Free Cash FlowC$ 13.65MC$ 3.21MC$ -3.97MC$ -21.55MC$ -33.17M
Operating Cash FlowC$ 20.01MC$ 10.68MC$ 5.91MC$ -6.08MC$ -2.09M
Investing Cash FlowC$ -5.95MC$ -5.19MC$ -9.48MC$ -15.35MC$ -30.83M
Financing Cash FlowC$ -6.32MC$ -3.14MC$ -4.19MC$ 25.46MC$ 33.25M

Currency in CAD

Cannara Biotech Earnings and Revenue History

-60M060M120M-800 %-400 %0 %400 %EarningsProfit Margin20182019202020212022202320242025RevenueEarningsProfit Margin

Cannara Biotech Liabilities to Assets

060M120M180M24 %36 %48 %60 %LiabilitiesLiabilities to Assets20182019202020212022202320242025AssetsLiabilitiesLiabilities to Assets

Cannara Biotech Cash Flow

-40M-20M020M40M60M20182019202020212022202320242025OperatingInvestingFinancing

Cannara Biotech Forecast EPS vs Actual EPS

000000.10.1Q3 25Q4 25Q1 26Q2 26Q3 26Q4 26EPS EstimateBeatMiss